Lifestance Health Group Inc
NASDAQ:LFST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lifestance Health Group Inc
NASDAQ:LFST
|
US |
Multiples-Based Value
The
Multiples-Based Value for
Lifestance Health Group Inc (LFST)
under the Base Case is
5.83
USD.
Compared with the current market price of 6.37 USD, the stock appears
Overvalued by 8%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
LFST Competitors Multiples
Lifestance Health Group Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Lifestance Health Group Inc
NASDAQ:LFST
|
2.5B USD | 1.8 | 261.2 | 32.3 | 105.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
91.3B USD | 0.2 | 51.6 | 13.5 | 13.5 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
66.4B EUR | 0.3 | 12.9 | 7.6 | 9.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
70.3B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
25B EUR | 1.1 | 19.7 | 9.4 | 14 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.9B EUR | 1.2 | 23.4 | 9 | 16.7 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 2 | 21.8 | 11.8 | 15.9 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD | 1.6 | 25 | 12 | 17.4 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.5 | 11 | 5.3 | 9.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.1B USD | 12.3 | -29 | -31.7 | -28.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.5B USD | 0.8 | 14.1 | 7.2 | 9.8 |